INTRODUCTION
Lysosomal storage diseases (LSDs) are a heterogeneous group of more than 40 genetic disorders. Most are due to the deficiency of a lysosomal hydrolase important for lysosomal degradation of macromolecules such as sphingolipids, glycosaminoglycans, glycogen, or glycoproteins. The pathology in patients with LSD depends on the nature of the accumulated undegraded substrate and the tissues in which the accumulated material is stored. Many LSDs affect the central nervous system; cells in the fixed-tissue macrophage system are also often the site of storage.
The neuronal ceroid lipofuscinoses (NCL), previously called Batten disease, are a heterogeneous group of at least 8 inherited LSDs that are, when taken together, the most common cause of progressive encephalopathy in childhood, with a world-wide incidence of approximately 1:10 000 births and a carrier frequency of 1% [1, 2] . Common to NCL patients are progressive neurodegenerative disease and accumulation of autofluorescent ceroid lipopigments in lysosomes in the central nervous system (CNS) and peripheral tissues [3] . Infantile neuronal ceroid lipofuscinosis (INCL), also referred to as Santavuori-Haltia disease, is the most rapidly progressive form of NCL and is caused by mutations in the CLN1 gene that encodes for the lysosomal enzyme palmitoyl-protein thioesterase-1 (PPT1) [4] , which cleaves fatty acyl chains from cysteine residues in proteins and is trafficked into lysosomes via the mannose 6phosphate receptor [5, 6] . It is one of the most abundant lysosomal enzymes in the brain [7] . Patients deficient in this enzyme inherit INCL as an autosomal recessive and have rapid disease progression beginning at around 1.5 years of age, with blindness, motor and mental decline, seizures, and lysosomal accumulation of granular osmiophilic deposits (GRODs) apparent by electron microscopy in many cell types, including neurons. The GRODs consist of saposins A and D and morphologically appear as lipopigment [2] . Brain atrophy with cortical and CA2 hippocampal neuronal storage and loss with associated astrogliosis occur [2, 8] . Death in childhood is due to neurodegenerative disease. Although autofluorescent lipopigment accumulates in many tissues, few studies of patients with INCL have described functionally significant manifestations of disease outside of the CNS [9] . One explanation for this lack of visceral symptoms is that patients succumb to neurological disease *Corresponding author, e-mail: voglerca@slu.edu before visceral manifestations are apparent. Therapy for patients with INCL is limited; hematopoietic stem cell transplantation is not recommended [10] , but brain-directed gene therapy [5] and drug therapy directed at disruption of thioester linkages [11, 12] have been proposed.
A murine knockout model of INCL in mice homozygous for a mutation in the gene that encodes the lysosomal enzyme PPT1 [13] has many clinical features similar to those seen in patients with INCL. Affected mice have neurological abnormalities by 8 months of age and usually die by 10 months of age. Myoclonic seizures, progressive spastic motor abnormalities [13] , and retinal dysfunction [5] are accompanied by progressive accumulation of GRODs in lysosomes in the brain, microglial activation, loss of GABAergic neurons, apoptosis, widespread astrocytosis, and cortical atrophy [14, 15] . Palmitoyl-protein thioesterase-1 mice have secondary elevation of other lysosomal enzymes, a biochemical feature common to many LSDs [5] , possibly mediated at both transcriptional and posttranscriptional levels [16] . This model has been used to test the efficacy of CNS-directed viral-mediated gene therapy using recombinant adenoassociated virus 2 encoding the human PPT1 cDNA [5, 17] .
Ultrastructural analysis of lysosomal storage accumulation over time in CNS and other tissues of PPT1 knockout mice reported here extends previous observations of the clinical, radiological, and morphological abnormalities in these mice. Alterations in cardiac morphology and function identified by ultrasound are also described.
METHODS
Palmitoyl-protein thioesterase-1-deficient mice were bred on a congenic C57BL/6 background [18] . Homozygous PPT1 null mice (ppt/ppt, PPT1 À/À) were generated through mutant-to-mutant mating; wild-type control animals from the same colony (þ/þ) were also evaluated. A 3-primer polymerase chain reaction assay was used to determine the genotype of the wild-type and PPT1 mice [13] . All mice were maintained by M.S.S. at Washington University (St Louis, MO, USA), and all animal procedures were carried out in accordance with National Institutes of Health guidelines and the Institutional Animal Care and Use Committee regulations of Washington University.
Morphological analysis was performed on tissues from mice at 1, 3, 5, and 7 months of age. Three PPT1 À/À mice and 3 wild-type control mice from each group were killed by cervical dislocation. Immediately following excision, tissue samples were immersion fixed in 4% paraformaldehyde and 2% glutaraldehyde in 0.1 M phosphate-buffered saline, postfixed in osmium tetroxide, and embedded in Spurr's resin (all reagents, Polysciences, Inc., Warrington, PA, USA). The parietal neocortex, hippocampus, cerebellum, liver, spleen, heart, aorta, kidney, retina, and bone and marrow from the rib were evaluated by light and electron microscopy for presence of storage material. Toluidine blue-stained 0.5-lm-thick sections were examined by light microscopy. For ultrastructural study, ultrathin sections stained with uranyl acetate and lead citrate were viewed in a 100CX JEOL transmission electron microscope.
Cardiac ultrasound was performed on PPT1 À/À mice and age-matched controls from 6 to 7.5 months of age. Noninvasive ultrasound examination of the cardiovascular system was performed using a Vevo770 Ultrasound System (VisualSonics, Inc, Toronto, ON, Canada). Mice were anesthetized with continuous inhalation of 1% gaseous isoflurane administered through a customized nose cone. The animals were secured on an imaging platform in supine position; physiologic parameters, including heart rate, respiratory rate, and core body temperature, were continuously monitored by built-in monitoring system. The anterior chest was shaved and ultrasonic coupling gel was applied. Ultrasound studies were performed using multiple transducers with different ultrasound frequencies (30 to 60 MHz) depending on the size and depth of the cardiovascular structure of interest. Care was taken to maintain adequate contact while avoiding excessive pressure on the chest. Complete 2-dimensional, M-mode, and Doppler ultrasound examination was performed from multiple views.
RESULTS

Clinical description
Prior to 7 months of age, the PPT1 À/À mice were phenotypically indistinguishable from normal littermates and bred normally. We have previously shown that by 7 months of age PPT1 À/À mice had significant motor abnormalities in both the constant speed and accelerating rotarod assay [17] . At 5 and 7 months, there was decreased retinal function and a subtle decrease in the number of photoreceptors [18] . At 7 months, PPT1 À/À mice developed progressive hunched posture with weight loss, scruffy fur, and decreased activity. By 8 months the affected mice had myoclonic seizures, the frequency of which increased with age. At 6, 6.5, 7, and 7.5 months of age, electroencephalography indicated that 0%, 0%, 50%, and 100% of the animals, respectively, had seizures [15] . An objective scoring system was developed to evaluate the interictal electroencephalography patterns [15, 17] . Electroencephalographs in 7-month-old and 7.5-month-old PPT1 À/À mice were significantly different from those observed in age-matched normal mice, with increased numbers of electrical discharges with greater amplitudes and an increase in burst/suppression patterns [15, 17] .
Pathology
At necropsy, none of the mice had enlarged spleens or pancreases, as has been described in another PPT-deficient mouse model [19] , and there were no gross abnormalities seen. The PPT1 À/À mice accumulated membrane-bound GRODs in multiple sites including brain, eye, liver, spleen, heart, aorta, peripheral nerve, and kidney ( Table 1 ). The ultrastructure of the storage was similar in all sites and resembled that seen in another murine model of INCL [20] as well as in infants with this disorder. Within all tissues examined, storage was progressive from 3 to 7 months of age (Table 1 ). In glomeruli, visceral and parietal glomerular epithelial cells and occasional mesangial cells had well-circumscribed membrane-bound accumulation of GRODs by 3 to 5 months of age, and the amount of storage increased progressively in 3-, 5-, and 7-month-old PPT1 À/À mice (Fig. 1a,b and Table 1 ). Tubular epithelial cells in PPT1 À/À mice had no osmiophilic storage at any age.
Large macrophages and rare sinus lining cells in the spleen and Kupffer cells in the liver had storage in older PPT1 À/À mice ( Fig. 2 and Table 1 ), but splenic lymphocytes and hepatocytes had no storage apparent by light or electron microscopy. There was no evidence of lysosomal storage material in spleens or livers from PPT1 À/À mice younger than 5 months of age. Rare osteocytes in bone from 3-, 5-, and 7-month-old PPT1 À/À mice had a small amount of storage. There was no storage in bone marrow cells or in chondrocytes, and bone architecture appeared normal by light microscopy.
Lysosomal storage material was most prominent in the CNS. Ultrastructural evidence of CNS storage was present as early as 1 month of age and then accumulated progressively with aging. Neocortical neurons, hippocampal pyramidal neurons, and Purkinje cells had abundant lysosomal storage of GRODs (Fig. 3) , and a lesser amount of storage was present in glial and endothelial cells (Fig.  4a,b ). Additional cellular changes of neuronal loss, astrocytosis, and prominent histiocytes were present in the CNS at 5 and 7 months. The neuronal loss affected the cerebral neocortex ( Fig. 5 ) and hippocampal pyramidal cell layers. Astrocytosis was present in these areas as well as in the cerebral and cerebellar white matter. The eyes from PPT1 À/À mice had GROD lysosomal storage in scleral fibroblasts, retinal pigment epithelium, and retinal neurons most prominent in the oldest mice examined.
In the heart, endothelial cells and occasional valve stromal cells contained GROD lysosomal storage in the 7month-old mice. Very rare small GROD accumulations were also present in myocardial cells. Samples of tissue from the media of the aortic arch showed abundant GRODs in smooth muscle cells in 7-month-old PPT1 mice ( Fig. 6 ). Clinical cardiac abnormalities and morphological abnormalities have been described in patients with NCLs as well as in the canine model of NCL [9, 21] . To characterize the cardiovascular phenotype in PPT1 À/À mice, a comprehensive noninvasive echocardiographic examination of the heart and ascending aorta was performed by a high-resolution ultrasound system (spatial resolution ;100 lm). Results are summarized in Table 2 . Although the difference in body weights did not reach statistical significance between wild-type and PPT1 À/À mice used in the ultrasound studies, it is well recognized that PPT1 À/À mice have smaller body mass; therefore, linear measurements of the left ventricle (LV) and aorta were indexed to body weight. Two-dimensional and Mmode echocardiography was used to evaluate LV structure and function. Measurements of LV wall thickness and chamber dimension showed a trend toward increased values in the PPT1 À/À mice, and calculated values based on these measurements revealed significantly increased LV mass index in comparison with wild-type controls (4.0 6 0.3 mg/ g vs. 3.6 6 0.3 mg/g, P , 0.05). Noninvasive parameters of LV systolic function (LV fractional shortening, velocity of circumferential shortening of the LV) showed no significant difference between the groups. To evaluate diastolic function of the LV, Doppler echocardiography was performed to measure transmitral blood-flow velocities. There was no significant difference detected between the groups with respect to early or late (atrial) absolute filling velocities (data not shown) or the ratio of these values (ratio of early over late [atrial] velocity of transmitral diastolic blood flow) ( Table 2 ). To characterize physiologically significant valvular involvement, Doppler echocardiography was performed to evaluate the presence of aortic and mitral stenosis and regurgitation. Pulse-wave Doppler mapping of proximal and distal transvalvular flow velocities showed no evidence of significant valvular abnormalities (data not shown).
To noninvasively evaluate in vivo aortic structure, 2-dimensional and M-mode echocardiography was used to measure the diameter of the ascending aorta from orthogonal views at multiple levels. These measurements showed significantly increased luminal diameters of the aorta in the PPT1 À/À mice at 3 different levels of the ascending aorta, most significantly at the level of the sinuses of Valsalva; even the nonindexed absolute values were significant at this level (Fig. 7) .
DISCUSSION
Infantile neuronal ceroid lipofuscinosis is an LSD that causes widespread progressive neurodegenerative changes with cerebral atrophy. The murine model of PPT1 deficiency shares many clinical features with INCL, including seizures and progressive motor and visual deficits. The storage material in the mice is morphologically identical to that seen in children with INCL. This model has been previously shown to have a thickened calvarium and autofluorescent lysosomal storage in neurons and glial cells in the cerebral Figure 4 . a. Storage is present in glial cells throughout the central nervous system in palmitoyl-protein-thioesterase-1 (PPT1) À/À mice. In the neocortex, a glial cell (a) from an adult PPT1 À/À mouse has abundant cytoplasmic granular osmiophilic deposits. b. Endothelial cells, here in the brain of a 7-month-old PPT1 À/À mouse, also contain lysosomal storage. (a and b: uranyl acetate-lead citrate; a, 36600 and b, 310 000 magnification). cortex, cerebellar Purkinje and granular cell layers, hippocampus, thalamus and hypothalamus, dentate nucleus, pons, and regions of the medulla [14, 15] . The cortex and hippocampus are atrophic. Neurons in the hippocampus, cerebral cortex, and Purkinje cell layer have ballooning degeneration and apoptosis with gliosis [13] . In the eye, there is progressive disorganization of the retina with pronounced thinning of the outer nuclear layer with aging. The number of photoreceptors in the outer nuclear layer decreases with age, and macrophage-like cells infiltrate the retina in INCL mice [18] . Figure 6 . The media of the aortic arch has abundant granular osmiophilic deposits in lysosomes in smooth muscle cells in an adult palmitoyl-protein-thioesterase-1 (PPT1) À/À mouse. This storage may contribute to the aortic dilatation apparent by ultrasound (uranyl acetate-lead citrate; 35000 magnification). Previous descriptions of CNS and eye morphology in PPT1 À/À mice have documented the occurrence of widespread autofluorescent storage and cell loss in the CNS accompanied by astrocytosis. This is the 1st description of the ultrastructural appearance and progressive nature of CNS storage in this murine model of INCL. The GRODs in PPT1 À/À mice were similar in ultrastructural appearance to those observed in human INCL [22] . Increasing accumulation of storage in the CNS and retina of PPT1 À/À mice with age correlates with reports of progressive severity of motor dysfunction and visual defects in these animals [18] .
We report here for the 1st time ultrastructural evidence of widespread storage in nonneural tissues in a murine model of INCL. Previous descriptions of storage within viscera in PPT1 À/À mice have been limited to identification of autofluorescent histiocytes in the spleen [13] . Here we report GRODs in every tissue examined. In particular, prominent progressive storage was observed in glomerular visceral and parietal epithelial cells and in mesangial cells and in smooth muscle cells in the media of the aorta. The visceral storage we observed could become clinically relevant if treatments to correct CNS storage are successful.
We extend previous observations of the morphological changes observed in the PPT1 À/À mouse model of INCL to include ultrastructural changes and evaluation of cardiac structure and function by ultrasound. The dilatation of the aortic root reported here could be due to primary structural abnormalities, such as perturbations of the elastic lamina related to the abundant GRODs observed in the smooth muscle cells. It has been demonstrated previously that the elastic lamina is disrupted by lysosomal storage material that accumulates in the aorta of mice with muropolysaccharidosis type I [23] . Future detailed study of the architecture of the elastic fibers in the aorta may provide evidence of alteration in PPT1 À/À mice, but our review failed to show any significant alteration. Dilatation of the aorta can also result as secondary changes from hemodynamic alterations associated with valvular abnormalities such as poststenotic dilatation, which occurs with aortic stenosis. However, we did not detect hemodynamically significant aortic stenosis, and thus we propose that the mild aortic dilatation observed in the PPT1 À/À mice is likely related to structural abnormalities of the aortic wall. Similarly, the increase in LV mass may be due to accumulation of GROD storage in the myocardium or secondary to hemodynamic stress. There was no detectable mitral regurgitation and no significant aortic valve insufficiency or stenosis in the PPT1 À/À mice; therefore, pressure or volume overload was not identified as a cause of the LV hypertrophy. Others have observed LV hypertrophy in patients with NCL [24, 25] but clinical evidence of aortic dilatation in these disorders has not been well described.
The cardiac findings in the PPT1 À/À mice are consistent with anatomical and histological findings in the hearts of children with NCLs. Cardiac pathology is a common finding in a number of lysosomal storage diseases [26] . Postmortem analysis of the hearts of several children with NCL, one with GRODs, demonstrated the accumulation of ceroid pigment in the muscle and valves with accompanying LV hypertrophy and fibrosis [9, 27] . Interest-ingly, the extent of cardiac disease appears to be more pronounced in children with the more protracted forms of NCL, such as juvenile neuronal ceroid lipofuscinosis [9, 27] . Therefore, we believe that the mouse model of INCL described here may have clinically relevant cardiac disease that would become more pronounced if CNS disease was effectively treated and if the animals lived longer.
Our detailed description of progressive accumulation of storage in the PPT1 À/À murine model of INCL provides a practical benchmark for evaluation of the efficacy of various therapies in correcting the cellular alterations caused by PPT1 deficiency in the CNS and viscera of these animals.
